IGF-1 LR3 – 0.1mg (10 vials)

Product Overview

IGF-1 LR3, also known as Long Arg3 IGF-1, is a modified synthetic analog of insulin-like growth factor 1 (IGF-1). It has structural modifications that distinguish it from native IGF-1 and make it a subject of specialized research into growth-factor activity.

Scientific interest in IGF-1 LR3 includes its interaction with IGF-related signaling pathways and its role in experimental studies of cellular growth and metabolism.

Scientific Background

IGF-1 is a peptide growth factor involved in several biological processes. Research into IGF-1 LR3 examines areas such as:

• Growth-factor signaling: Investigated for its interaction with pathways associated with IGF activity.
• Cellular biology: Studied in experimental models involving cell growth and differentiation.
• Metabolic pathways: Examined for its relationship with cellular metabolic signaling.
• Molecular research: Used in specialized investigations of modified IGF-1 analogs.

These research areas do not establish clinical benefits or demonstrate that IGF-1 LR3 is safe or effective for muscle growth, recovery, or other human applications.

Product Specifications

• Product Name: IGF-1 LR3
• Listed Strength: 0.1mg (100mcg)
• Package Size: 10 vials
• Compound Classification: Synthetic IGF-1 analog
• Research Focus: Growth-factor signaling and cellular biology

Product Information and Verification

Before publishing this listing, verify the exact peptide identity, amino acid sequence, formulation, labeled strength, vial quantity, storage requirements, and supplier documentation.

Strength clarification: Confirm whether 0.1mg (100mcg) refers to each individual vial or the combined amount across all 10 vials. Ensure the product title accurately reflects the supplier’s labeling.

Do not make unsupported claims about purity, independent laboratory testing, certificates of analysis, or therapeutic effectiveness.

Safety and Regulatory Disclaimer

IGF-1 LR3 is an investigational compound. Its safety and efficacy for human therapeutic use have not been established. It should not be presented as an approved medicine or as a proven treatment for growth hormone deficiency, muscle development, or other medical conditions.

IGF-related compounds can affect important biological pathways, and unverified products may carry significant risks. Product labeling, advertising, and distribution must comply with applicable laws and regulations.

This description is provided for general scientific and educational purposes only and is not medical advice.